Thus, TIGIT and DNAM-1 can compete for binding to PVR and Nectin-2 which are highly expressed on tumour cells and are also upregulated by exposure to cytokines, such as IFN-γ and TNF-α [3]. The gene discussed is TIGIT; the disease is neoplasm.